adenosine thiamine triphosphate: structure in first source
adenosine thiamine triphosphate : An adenosine 5'-phosphate obtained by formal condensation of the hydroxy group of thiamine with the triphosphate group of ATP.
adenosine thiamine triphosphate(2-) : An organophosphate oxoanion obtained by deprotonation of the triphosphate OH groups of adenosine thiamine triphosphate.
ID Source | ID |
---|---|
PubMed CID | 15938961 |
CHEBI ID | 71393 |
MeSH ID | M0509471 |
Synonym |
---|
NCHEMBIO867-COMP1 |
adenosine thiamine triphosphate |
atp-thiamine(2-) |
adenosine thiamine triphosphate(2-) |
thiamine-atp(2-) |
5'-o-{[({[(2-{3-[(4-azaniumyl-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl}ethoxy)phosphinato]oxy}phosphinato)oxy]phosphinato}adenosine |
CHEBI:71393 |
Q27139578 |
[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-oxidophosphoryl] [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate |
Adenosine thiamine triphosphate (AThTP) is a nucleotide discovered in bacteria and some other living organisms more than a decade ago.
Excerpt | Reference | Relevance |
---|---|---|
"Adenosine thiamine triphosphate (AThTP) is a nucleotide discovered in bacteria and some other living organisms more than a decade ago. " | ( Synthesis, physico-chemical properties and effect of adenosine thiamine triphosphate on vitamin B Kolas, IK; Kudyrka, TG; Luchko, TA; Makar, AA; Makarchikov, AF; Rusina, IM; Usanov, SA; Yantsevich, AV, 2022) | 2.41 |
Class | Description |
---|---|
organophosphate oxoanion | An organic phosphoric acid derivative in which one or more oxygen atoms of the phosphate group(s) has been deprotonated. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.51) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |